Skip to content

Logs: Bennett Institute

The following is a list of all job requests run via OpenSAFELY by Bennett Institute users.
Status Project Workspace Request ID Backend Jobs User Started View request
Failed GP appointments during COVID winter-pressures 16233 TPP 2/3 Colm Andrews 3 years, 6 months ago 10 March 2023 16:32:25 UTC View, Job request 16233
Failed GP appointments during COVID winter-pressures 16232 TPP 0/1 Colm Andrews 3 years, 6 months ago 10 March 2023 16:28:52 UTC View, Job request 16232
Succeeded Coverage, effectiveness and safety of neutralising monoclonal antibodies or antivirals for non-hospitalised patients with COVID-19 paxlovid_sotrovimab 16225 TPP 1/1 Bang Zheng 3 years, 6 months ago 10 March 2023 12:30:19 UTC View, Job request 16225
Succeeded Coverage, effectiveness and safety of neutralising monoclonal antibodies or antivirals for non-hospitalised patients with COVID-19 paxlovid_sotrovimab 16223 TPP 2/2 Bang Zheng 3 years, 6 months ago 10 March 2023 11:54:12 UTC View, Job request 16223
Succeeded Service Restoration Observatory sro-measures-dashboard-updating 16222 TPP 17/17 Rose Higgins 3 years, 6 months ago 10 March 2023 11:40:14 UTC View, Job request 16222
Failed Coverage, effectiveness and safety of neutralising monoclonal antibodies or antivirals for non-hospitalised patients with COVID-19 paxlovid_sotrovimab 16220 TPP 1/2 Bang Zheng 3 years, 6 months ago 10 March 2023 10:39:16 UTC View, Job request 16220
Succeeded OpenSAFELY Internal opensafely-internal-interactive 16219 TPP 9/9 Lucy Bridges 3 years, 6 months ago 10 March 2023 10:21:43 UTC View, Job request 16219
Succeeded Coverage, effectiveness and safety of neutralising monoclonal antibodies or antivirals for non-hospitalised patients with COVID-19 paxlovid_sotrovimab 16218 TPP 2/2 Bang Zheng 3 years, 6 months ago 10 March 2023 10:20:13 UTC View, Job request 16218
Failed Coverage, effectiveness and safety of neutralising monoclonal antibodies or antivirals for non-hospitalised patients with COVID-19 paxlovid_sotrovimab 16217 TPP 0/2 Bang Zheng 3 years, 6 months ago 10 March 2023 10:17:35 UTC View, Job request 16217
Failed Coverage, effectiveness and safety of neutralising monoclonal antibodies or antivirals for non-hospitalised patients with COVID-19 paxlovid_sotrovimab 16216 TPP 0/1 Bang Zheng 3 years, 6 months ago 10 March 2023 09:19:31 UTC View, Job request 16216
Succeeded Coverage, effectiveness and safety of neutralising monoclonal antibodies or antivirals for non-hospitalised patients with COVID-19 paxlovid_sotrovimab 16215 TPP 2/2 Bang Zheng 3 years, 6 months ago 10 March 2023 09:18:25 UTC View, Job request 16215
Succeeded Coverage, effectiveness and safety of neutralising monoclonal antibodies or antivirals for non-hospitalised patients with COVID-19 paxlovid_sotrovimab 16214 TPP 1/1 Bang Zheng 3 years, 6 months ago 10 March 2023 09:11:05 UTC View, Job request 16214
Failed Coverage, effectiveness and safety of neutralising monoclonal antibodies or antivirals for non-hospitalised patients with COVID-19 paxlovid_sotrovimab 16213 TPP 0/2 Bang Zheng 3 years, 6 months ago 10 March 2023 09:07:12 UTC View, Job request 16213
Failed Coverage, effectiveness and safety of neutralising monoclonal antibodies or antivirals for non-hospitalised patients with COVID-19 paxlovid_sotrovimab 16212 TPP 1/2 Bang Zheng 3 years, 6 months ago 10 March 2023 08:37:52 UTC View, Job request 16212
Succeeded Coverage, effectiveness and safety of neutralising monoclonal antibodies or antivirals for non-hospitalised patients with COVID-19 paxlovid_sotrovimab 16211 TPP 2/2 Bang Zheng 3 years, 6 months ago 10 March 2023 08:23:07 UTC View, Job request 16211
Failed Coverage, effectiveness and safety of neutralising monoclonal antibodies or antivirals for non-hospitalised patients with COVID-19 paxlovid_sotrovimab 16210 TPP 1/2 Bang Zheng 3 years, 6 months ago 10 March 2023 07:52:11 UTC View, Job request 16210
Succeeded Coverage, effectiveness and safety of neutralising monoclonal antibodies or antivirals for non-hospitalised patients with COVID-19 paxlovid_sotrovimab 16209 TPP 2/2 Bang Zheng 3 years, 6 months ago 10 March 2023 07:27:18 UTC View, Job request 16209
Succeeded Effectiveness of sotrovimab/molnupiravir use vs non-use mabsavs-usernonuser-ccw 16208 TPP 18/18 Linda Nab 3 years, 6 months ago 09 March 2023 19:31:53 UTC View, Job request 16208
Succeeded Effectiveness of sotrovimab/molnupiravir use vs non-use mabsavs-usernonuser-ccw 16207 TPP 12/12 Linda Nab 3 years, 6 months ago 09 March 2023 19:08:32 UTC View, Job request 16207
Succeeded Effectiveness of sotrovimab/molnupiravir use vs non-use mabsavs-usernonuser-ccw 16205 TPP 6/6 Linda Nab 3 years, 6 months ago 09 March 2023 18:39:50 UTC View, Job request 16205
Succeeded Effectiveness of sotrovimab/molnupiravir use vs non-use mabsavs-usernonuser-ccw 16204 TPP 6/6 Linda Nab 3 years, 6 months ago 09 March 2023 18:32:30 UTC View, Job request 16204
Succeeded Effectiveness of sotrovimab/molnupiravir use vs non-use mabsavs-usernonuser-ccw 16203 TPP 6/6 Linda Nab 3 years, 6 months ago 09 March 2023 17:50:01 UTC View, Job request 16203
Succeeded Effectiveness of sotrovimab/molnupiravir use vs non-use mabsavs-usernonuser-ccw 16202 TPP 6/6 Linda Nab 3 years, 6 months ago 09 March 2023 17:08:28 UTC View, Job request 16202
Succeeded Effectiveness of sotrovimab/molnupiravir use vs non-use mabsavs-usernonuser-ccw 16197 TPP 66/66 Linda Nab 3 years, 6 months ago 09 March 2023 16:19:48 UTC View, Job request 16197
Succeeded Effectiveness of sotrovimab/molnupiravir use vs non-use mabsavs-usernonuser-ccw 16194 TPP 6/6 Linda Nab 3 years, 6 months ago 09 March 2023 15:56:06 UTC View, Job request 16194